ACT Brief: AI, Caplyta Approval, and FDA Priority Vouchers

from Applied Clinical Trials · host Applied Clinical Trials

In today’s ACT Brief, we explore how AI and tokenized data are improving patient-protocol matching, highlight Caplyta’s new FDA approval for major depressive disorder, and review the FDA’s expansion of its National Priority Voucher program.

Episode metadata supplied by the publisher feed · Published Nov 10, 2025

Embed this episode

Attribution link and audio player

Ready to play

ACT Brief: AI, Caplyta Approval, and FDA Priority Vouchers

0:00 2:25

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Applied Clinical Trials?

This episode is 2 minutes long.

When was this Applied Clinical Trials episode published?

This episode was published on November 10, 2025.

Can I download this Applied Clinical Trials episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!